Increasing Prevalence of Alopecia and R&D of New Therapies to Augment Growth of Androgenetic Alopecia Treatment Market

 

Androgenetic Alopecia Treatment Market

Increasing prevalence of alopecia is expected to propel growth of the androgenetic alopecia market. For instance, according to a 2019 survey released by the China Association of Health Promotion and Education (CAHEP), one out of six Chinese people, or about 250 million people, are suffering from hair loss.

R&D of new therapies is expected to offer lucrative growth opportunities for players in the global androgenetic alopecia treatment market. For instance, in February 2021, Histogen Inc. announced that the company’s Phase 1b/2a clinical trial of HST-001 or hair stimulating complex, which is intended to be a physician-administered therapeutic for hair loss, demonstrated significant change from baseline in total hairs (terminal and vellus) in the target area. Moreover, adoption of stem cell therapy is also expected to aid in growth of the market. For instance, in May 2020, researchers from MEDIPOST Co., Ltd. and Chung-Ang University College of Medicine, South Korea, Primed mesenchymal stromal cells-derived conditioned medium improved androgenetic alopecia through producing an increased hair density, thickness, and growth rate.

Limited efficacy and lack of evidences suggesting clinical efficacy of available hair loss drugs is expected to hamper growth of the androgenetic alopecia treatment market.

Among regions, North America is expected to witness significant growth in the global androgenetic alopecia treatment market, owing to R&D of new therapies. For instance, in June 2019, Aclaris Therapeutics, Inc., a biopharmaceutical company, announced positive results from a Phase 2 open-label clinical trial of ATI-502, an investigational topical Janus Kinase (JAK) 1/3 inhibitor, in patients with androgenetic alopecia.

Competitive Analysis

Major players operating in the global androgenetic alopecia treatment market are Histogen Inc., Cipla Limited, Aclaris Therapeutics, Inc., Applied Biology, Inc., Merck & Co., Inc., Daiichi-Sankyo Co., Ltd., Johnson and Johnson Services, Inc., Lexington International LLC, Vita-Cos-Med Klett-Loch GmbH, PureTech, Vitabiotics, Dr. Reddy’s Laboratories, HCell Inc., Follica, Inc., and Ranbaxy Laboratories Ltd. among others.

Major players operating in the global androgenetic alopecia treatment market are focused on R&D to expand their product portfolio. For instance, in June 2020, Follica, Inc. announced positive feedback from a meeting with the U.S. Food and Drug Administration as the company prepares to advance its lead program into Phase 3 development. Similarly, in May 2020, Applied Biology, Inc. partnered with Regeus, a biotech company and a division of Gurus BioPharm, for R&D in treatment of androgenetic alopecia.

Comments

Post a Comment

Popular posts from this blog

Astrum Has Expanded Its Presence In India Infrared Thermometer Market

Image
  The Infrared Thermometer market is witnessing the fastest growth in the Asia Pacific region and this can be accredited to the growing aging population in the region which is driving demand for healthcare services. Japan has the highest growing aging population in the country. According to the Statistics Bureau, Ministry of Internal Affairs and Communications, in 2019, the aged population (65 years old and over) was 35.89 million, constituting 28.4 percent of the total population (i.e., 1 in every 4 persons) and marking a record high in Japan. The rise in prevalence of infectious disease and increase in the demand for the product for newborns as children cannot hold the contact thermometer is playing a key role in the overall development of the infrared thermometer market . According to the World Health Organization, HIV, tuberculosis, malaria, neglected tropical diseases, and viral hepatitis affects billions of people around the world and causes more than 4 million deaths each year
Read more

Cfmoto Has Announced The Launch Of Its Electric Concept ATV To Expand Its Business In The Global All-Terrain Vehicle (ATV) Lighting Systems Market

Image
  A growing number of ATV racing events across the globe is driving the growth of the all-terrain vehicle (ATV) lighting systems market . For instance, MX sports have scheduled 10 ATV events for the year 2020. Such racing events are increasing the popularity of ATV bikes and are expected to drive market growth during the forecast period. The growing popularity of ATV across developing countries is again contributing to the growth of the market. For instance, in March 2019, Auto Sports India organized an ATV championship in three categories: Drag race, Solo Dirt Race, and Endurance Race in Goa. Moreover, the growing focus of key players to introduce electric all-terrain vehicles is further projected to augment the growth of the all-terrain vehicle (ATV) lighting systems market. For instance, in December 2018, Ecocharger Company has announced the launch of electric ATV vehicle. North America is expected to hold the global all-terrain vehicle (ATV) lighting systems market and this is
Read more

The Global Meningococcal Vaccines Market Continues To Grow Owing To the Demand from Healthcare Care Sectors across the World to Prevent the Spread of the Diseases Especially In Children

Image
  Meningococcal vaccines prevent the contraction of meningococcal diseases, including meningitis caused by the bacteria called meningococcus aureus. An outbreak of meningococcal disease is usually followed by an onset of meningitis. Meningococcal meningitis can cause permanent damage to the brain or spinal cord in as little as 10 days, depending on the degree of infection and the natural immunity of the person. Since meningitis is usually associated with a fever and signs and symptoms of a serious illness, many parents prefer not to use the traditional treatments for their children such as meningitis or oral antibiotics. Instead, they often resort to various forms of therapeutic interventions that may even improve their chances of developing a positive outcome. Meningococcal vaccines are now available for meningococcal meningitis, as well as for men who have had other prior bouts of meningitis. Some vaccines used for these purposes are PPSV, Rallo, and Q fever type 1. These vaccines
Read more